Snapshot · Russell 3000 · generated 2026-09-19 21:53 UTC

ELVN — Enliven Therapeutics, Inc.

N/A · Quality 39/100

ELVN - Enliven Therapeutics, Inc.
Data generated 2026-09-19 21:53 UTC (nightly scan, universe: Russell 3000).
Price: 49.45 USD
Valuation: N/A
Value Score: 21.9
Quality: 39/100
Moat score: 8.3 (erosion: none)
N/A - Quality 39/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/ELVN
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

49.45

Intrinsic value

Margin of safety

Implied growth (reverse DCF)

a described calculation from stated inputs, not a forecast

Value Score

21.9

Quality

Psychology

19.1

Discovery

55.6

price/volume attention only

Moat score

8.3

erosion: none

Value Score: bottom 34% of Russell 3000 · Quality: bottom 24%

Open the interactive Deep Dive for ELVN →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/ELVN - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

What is Enliven Therapeutics, Inc.'s Value Score?

Enliven Therapeutics, Inc.'s Value Score is 21.9 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number. This is a described calculation from public data, not a recommendation.